Recruiting Bladder Cancer Studies in Ocala
Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies
This study is a Phase I/II, multicenter, first-in-human, open-label dose-escalation study of BT8009 given as a single agent and in combination with pembrolizumab in participants with advanced solid tu...
Safety and Preliminary Anti-Tumor Activity of TYRA-300 in Advanced Urothelial Carcinoma and Other Solid Tumors With FGFR3 Gene Alterations
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (PK), and preliminary antitumor activity of TYRA-300 in cancers with FGFR3 activating gene alterations, including lo...
About Bladder Cancer Clinical Trials in Ocala
Bladder cancer occurs in the tissues of the bladder and is one of the most common cancers. It has a high recurrence rate, requiring ongoing monitoring. Treatments include surgery, intravesical therapy, chemotherapy, and immunotherapy.
There are currently 2 bladder cancer clinical trials recruiting participants in Ocala, FL. These studies are seeking a combined 639 participants. Research is being sponsored by BicycleTx Limited, Tyra Biosciences, Inc. Clinical trial participation is free and participants receive study-related medical care at no cost.
Bladder Cancer Clinical Trials in Ocala — FAQ
Are there bladder cancer clinical trials in Ocala?
Yes, there are 2 bladder cancer clinical trials currently recruiting in Ocala, FL. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Ocala?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Ocala research site will contact you about next steps.
Are clinical trials in Ocala free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Ocala studies also compensate for your time and travel.
What bladder cancer treatments are being tested?
The 2 active trials in Ocala are testing new therapies including novel drugs, biologics, and treatment approaches for bladder cancer.
Data updated March 2, 2026 from ClinicalTrials.gov